Advances in high-density lipoprotein physiology: surprises, overturns, and promises C Constantinou, EA Karavia, E Xepapadaki, PI Petropoulou, E Papakosta, ... American Journal of Physiology-Endocrinology and Metabolism, 2016 | 54 | 2016 |
HDL and type 2 diabetes: the chicken or the egg? E Xepapadaki, I Nikdima, EC Sagiadinou, E Zvintzou, KE Kypreos Diabetologia 64, 1917-1926, 2021 | 46 | 2021 |
Pleiotropic effects of apolipoprotein C3 on HDL functionality and adipose tissue metabolic activity [S] E Zvintzou, M Lhomme, S Chasapi, S Filou, V Theodoropoulos, ... Journal of lipid research 58 (9), 1869-1883, 2017 | 44 | 2017 |
The olive constituent oleuropein, as a PPARα agonist, markedly reduces serum triglycerides F Malliou, I Andreadou, FJ Gonzalez, A Lazou, E Xepapadaki, I Vallianou, ... The Journal of nutritional biochemistry 59, 17-28, 2018 | 42 | 2018 |
HDL quality and functionality: what can proteins and genes predict? EA Karavia, E Zvintzou, PI Petropoulou, E Xepapadaki, C Constantinou, ... Expert review of cardiovascular therapy 12 (4), 521-532, 2014 | 42 | 2014 |
Τhe antioxidant function of HDL in atherosclerosis E Xepapadaki, E Zvintzou, C Kalogeropoulou, S Filou, KE Kypreos Angiology 71 (2), 112-121, 2020 | 41 | 2020 |
Scavenger receptor class B type I regulates plasma apolipoprotein E levels and dietary lipid deposition to the liver EA Karavia, NI Papachristou, GC Sakellaropoulos, E Xepapadaki, ... Biochemistry 54 (36), 5605-5616, 2015 | 29 | 2015 |
Impact of apolipoprotein A1-or lecithin: cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in mice E Xepapadaki, G Maulucci, C Constantinou, EA Karavia, E Zvintzou, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1865 (6 …, 2019 | 20 | 2019 |
Pharmacological management of dyslipidemia in atherosclerosis: limitations, challenges, and new therapeutic opportunities KE Kypreos, R Bitzur, EA Karavia, E Xepapadaki, G Panayiotakopoulos, ... Angiology 70 (3), 197-209, 2019 | 20 | 2019 |
Site-specific effects of apolipoprotein E expression on diet-induced obesity and white adipose tissue metabolic activation A Hatziri, C Kalogeropoulou, E Xepapadaki, E Birli, EA Karavia, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (2), 471-480, 2018 | 17 | 2018 |
Deficiency in apolipoprotein AI ablates the pharmacological effects of metformin on plasma glucose homeostasis and hepatic lipid deposition EA Karavia, A Hatziri, C Kalogeropoulou, NI Papachristou, E Xepapadaki, ... European Journal of Pharmacology 766, 76-85, 2015 | 16 | 2015 |
Pleiotropic effects of apolipoprotein A-Ⅱ on high-density lipoprotein functionality, adipose tissue metabolic activity and plasma glucose homeostasis E Zvintzou, E Xepapadaki, C Kalogeropoulou, S Filou, KE Kypreos Journal of Biomedical Research 34 (1), 14, 2020 | 14 | 2020 |
Apolipoprotein E in diet-induced obesity: a paradigm shift from conventional perception KE Kypreos, EA Karavia, C Constantinou, A Hatziri, C Kalogeropoulou, ... Journal of Biomedical Research 32 (3), 183, 2018 | 14 | 2018 |
High density lipoprotein in atherosclerosis and coronary heart disease: Where do we stand today? E Zvintzou, DS Karampela, A Vakka, E Xepapadaki, EA Karavia, A Hatziri, ... Vascular pharmacology 141, 106928, 2021 | 12 | 2021 |
Isoform and tissue dependent impact of apolipoprotein E on adipose tissue metabolic activation: The role of apolipoprotein A1 C Kalogeropoulou, A Hatziri, E Xepapadaki, O Savvoulidou, EA Karavia, ... Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2020 | 7 | 2020 |
Adrenoceptor‐related decrease in serum triglycerides is independent of PPAR α activation M Konstandi, KE Kypreos, T Matsubara, E Xepapadaki, YM Shah, ... The FEBS journal 286 (21), 4328-4341, 2019 | 5 | 2019 |
Tissue-specific functional interaction between apolipoproteins A1 and E in cold-induced adipose organ mitochondrial energy metabolism E Xepapadaki, I Nikdima, E Zvintzou, EA Karavia, KE Kypreos Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2021 | 4 | 2021 |
High density lipoprotein: The role of apolipoprotein A2 E Xepapadaki, C Kalogeropoulou, E Zvintzou, S Filou, KE Kypreos Hell. J. Atheroscler. 9, 128-137, 2018 | 4 | 2018 |
High-Density Lipoprotein in Metabolic Disorders and Beyond: An Exciting New World Full of Challenges and Opportunities E Zvintzou, E Xepapadaki, G Skroubis, V Mparnia, K Giannatou, ... Pharmaceuticals 16 (6), 855, 2023 | 1 | 2023 |
Benefits of a fixed-dose combination of standardized P. mume extract with choline on adipose tissue mitochondrial metabolic activity and pancreatic β-islet secretory capacity … EC Sagiadinou, EA Karavia, E Xepapadaki, E Zvintzou, A Hatziri, ... Phytomedicine Plus 2 (3), 100317, 2022 | 1 | 2022 |